CAROLE RUMBERGER: Open Payments
NPI 1215458641 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 16 payments from 7 companies in 2025. Trend: 2023 $237 · 2024 $162 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $118 |
| Janssen Pharmaceuticals, Inc | 3 | $101 |
| Lundbeck LLC | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: Auvelity, SPRAVATO, REXULTI, Qelbree, VRAYLAR, CAPLYTA, FANAPT.
Industry payments across NY — which companies pay providers there.
